These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35298817)

  • 1. Rapid Rational Design of Cyclic Peptides Mimicking Protein-Protein Interfaces.
    Santini BL; Zacharias M
    Methods Mol Biol; 2022; 2405():231-244. PubMed ID: 35298817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid
    Santini BL; Zacharias M
    Front Chem; 2020; 8():573259. PubMed ID: 33134275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miniaturized proteins: the backbone cyclic proteinomimetic approach.
    Kasher R; Oren DA; Barda Y; Gilon C
    J Mol Biol; 1999 Sep; 292(2):421-9. PubMed ID: 10493885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of glycosaminoglycan binding cyclic peptides using cPEPmatch.
    Santini BL; Gaardløs M; Wyrzykowski D; Rothemund S; Penk A; Zacharias M; Samsonov SA
    Comput Struct Biotechnol J; 2024 Dec; 23():2985-2994. PubMed ID: 39135886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic peptides: backbone rigidification and capability of mimicking motifs at protein-protein interfaces.
    Huang H; Damjanovic J; Miao J; Lin YS
    Phys Chem Chem Phys; 2021 Jan; 23(1):607-616. PubMed ID: 33331371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual screening using combinatorial cyclic peptide libraries reveals protein interfaces readily targetable by cyclic peptides.
    Duffy FJ; O'Donovan D; Devocelle M; Moran N; O'Connell DJ; Shields DC
    J Chem Inf Model; 2015 Mar; 55(3):600-13. PubMed ID: 25668361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational analysis of binding of P1 variants to trypsin.
    Brandsdal BO; Aqvist J; Smalås AO
    Protein Sci; 2001 Aug; 10(8):1584-95. PubMed ID: 11468355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
    Scheidig AJ; Hynes TR; Pelletier LA; Wells JA; Kossiakoff AA
    Protein Sci; 1997 Sep; 6(9):1806-24. PubMed ID: 9300481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rigidification of a flexible protease inhibitor variant upon binding to trypsin.
    Hanson WM; Domek GJ; Horvath MP; Goldenberg DP
    J Mol Biol; 2007 Feb; 366(1):230-43. PubMed ID: 17157870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cation-pi interactions in biomolecular association. Design of peptides favoring interactions between cationic and aromatic amino acid side chains.
    Pletneva EV; Laederach AT; Fulton DB; Kostic NM
    J Am Chem Soc; 2001 Jul; 123(26):6232-45. PubMed ID: 11427046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation.
    Qvit N; Kornfeld OS
    J Vis Exp; 2016 Jan; (107):e53589. PubMed ID: 26863382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic cyclization of a potent bowman-birk protease inhibitor, sunflower trypsin inhibitor-1, and solution structure of an acyclic precursor peptide.
    Marx UC; Korsinczky ML; Schirra HJ; Jones A; Condie B; Otvos L; Craik DJ
    J Biol Chem; 2003 Jun; 278(24):21782-9. PubMed ID: 12621047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a serine protease poised to resynthesize a peptide bond.
    Zakharova E; Horvath MP; Goldenberg DP
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11034-9. PubMed ID: 19549826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity cyclic peptide matriptase inhibitors.
    Quimbar P; Malik U; Sommerhoff CP; Kaas Q; Chan LY; Huang YH; Grundhuber M; Dunse K; Craik DJ; Anderson MA; Daly NL
    J Biol Chem; 2013 May; 288(19):13885-96. PubMed ID: 23548907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI.
    Perona JJ; Tsu CA; Craik CS; Fletterick RJ
    J Mol Biol; 1993 Apr; 230(3):919-33. PubMed ID: 7683059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.
    Müller G; Gurrath M; Kessler H
    J Comput Aided Mol Des; 1994 Dec; 8(6):709-30. PubMed ID: 7738606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational approaches to developing short cyclic peptide modulators of protein-protein interactions.
    Duffy FJ; Devocelle M; Shields DC
    Methods Mol Biol; 2015; 1268():241-71. PubMed ID: 25555728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal Structures of Protein-Bound Cyclic Peptides.
    Malde AK; Hill TA; Iyer A; Fairlie DP
    Chem Rev; 2019 Sep; 119(17):9861-9914. PubMed ID: 31046237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local conformations of peptides representing the entire sequence of bovine pancreatic trypsin inhibitor and their roles in folding.
    Kemmink J; Creighton TE
    J Mol Biol; 1993 Dec; 234(3):861-78. PubMed ID: 7504737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.